email hidden said:Solving the Antioxidant Question in Aids
Published on Monday, March 26, 2007
by Healthy News Service
http://www.healthy.net/scr/news.asp?Id=9035
Well, more polemical nonsense.
Glutathione depletion is not seen in every person with HIV.
Antioxidants are NOT a cure for AIDS.
That being said, restoring and/or maintaining glutathione levels is an
important part of a comprehensive approach to managing HIV disease.
Selenium, a multivitamin, N-acetylcysteine, whey proteins, alpha
lipoic acid--all are important parts of a complete regimen. And when
needed, antiretroviral therapy is essential.
I have been doing this work for nearly 18 years and I can tell you,
none of that cures HIV disease. But together, they can help people
approach an expectation of a normal life span.
To say antiviral drugs are not necessary is lethally stupid. As most
HIV+ denialists have discovered: most of them have died of AIDS.
Mathias Rath is a bonehead and a murderer. Not quite as bad as the
lowlife scum at Abbott Pharmaceuticals, but almost.
George M. Carter
***
As if murdering PWAs with exorbitant pricing isn't enough, now they
attack people directly.
George M. Carter
***
http://www.eatg.org/news/newsitem.php?id=1911
Abbott sues Act Up-Paris
Tuesday, June 12, 2007
Drug company sues PLWAs for the first time
Pharmaceutical company Abbott decided to sue PLWAs group Act Up-Paris
in response to the April 26th, 2007 netstrike we organized against the
drug manufacturer: the first time a drug company has used legal action
against us. Yet this strategy will force Abbott to justify its
criminal decisions, which are depriving PLWAs in Tha land of the
company’s new drugs, effectively sentencing them to death.
* The True Crime: Abbott’s policy
Last December, Tha land issued compulsory licenses on several drugs,
one of them patented by Abbott. By licensing particular drugs, the
Thai government can produce or import less expensive, generic copies
of the medicines, allowing the Thai health system to vastly increase
the number of patients it treats.
Even though the Thai government’s decision explicitly respects
international agreements on intellectual property, Abbott decided to
retaliate in a brand new way: by refusing to register its new
drugs-including the heat-stable Kaletra, a second line drug, needed by
PLWAs in the case of therapeutic failure-in Thailand. Abott is
effectively sentencing Thai AIDS patients to death.
* No Possible Appeal
Abbott’s decision went against international agreements on
intellectual property (TRIPS) signed by the government members of the
WTO. But the very same agreements don’t provide an appeal process to
the WTO in the case that a private industrial group decides to ignore
them. Only governments are accountable to the WTO. Though illegitimate
and criminal, Abbott’s decision is not legally questionable.
The WHO and, for instance, the French Minister of Foreign Affairs,
supported the Thai government’s decision. Numerous doctors and
researchers denounced Abbott’s retaliation and called for a boycott of
the company’s products, a very rare act by health workers. Among the
shareholders, a strong minority urged the company’s leaders to step
back and to withdraw their criminal decision. Without any result.
* Public Challenge, the Last Weapon Abbott Wants to Deprive us of
To defend their lives, the only option for PLWAs was to publicly
challenge the company. On April 26, the day before the General
Assembly of Abbott’s shareholders, a network of Thai PLWAs called for
an international day of action, supported by NGOs around the world.
Act Up-Paris called upon activists all over the world to participate
in a netstrike. Hundreds, even thousands of people in France,
Thailand, the U.S. and elsewhere, repeatedly visited Abbott’s website
in order to force a slowing down of its servers.
Three weeks later, Abbott filed a complaint against Act Up-Paris. The
laboratory wants us to be condemned for “service denial.” Should this
be accepted by the court, we could be sentenced to very high
penalties. The fine could reach $50,000, not including liabilities, a
communique release of the verdict (paid communication) and legal
expenses. These expenses would be incredibly damaging to our
organization and are a drop in the bucket compared to Abbott’s
profits. This legal action is clearly an attempt by the laboratory to
silence Act Up-Paris.
* Bringing Abbott’s suit rather than Act Up’s
The legal article Abbott is using against Act Up-Paris stipulates that
it is forbidden to limit the access to a website, unless the defendant
acted under a “legitimate motive”. Is defending patients’ lives
against profit illegitimate? The call for a boycott issued by Thai
patients, public declarations made by the WHO and officials in the
French government, as well as political actions around the world
supports the
legitimacy of our motive.
By suing us, Abbott will have to prove that the lives of thousands of
Thai people is not legitimate enough a motive to criticize publicly a
medicine company. The lawsuit the laboratory is bringing against us,
patients, will reveal to the world the very obscenity of Abbott’s
actions in Thailand.
***We request from Abbott’s leaders to:
-- Stop threatening countries which are doing nothing more than
resorting to their rights, in agreement/compliance with international
treaties.
-- Withdraw their decision to put to death thousands of HIV+ people in
Thailand.
-- Take back their complaint against Act Up-Paris.
SOURCE: Act Up-Paris